精华制药：XXXX年半年度财务报告 XXXX-07-30

南通精华制药股份有限公司2010年半年度财务报告1财务报告（未经审计）一、财务报表1、资产负债表编制单位：南通精华制药股份有限公司2010年06月30日单位：元期末余额年初余额项目合并母公司合并母公司流动资产：货币资金387,296,610.81376,886,130.8657,087,160.1846,671,080.22结算备付金拆出资金交易性金融资产应收票据80,000.0080,000.00应收账款23,256,487.6723,146,923.8330,623,816.4630,526,394.36预付款项17,227,734.0517,227,734.052,159,095.892,159,095.89应收保费应收分保账款应收分保合同准备金应收利息2,042,102.272,042,102.27应收股利其他应收款348,290.56348,290.56850,878.46850,878.46买入返售金融资产存货50,050,530.1250,024,530.3733,194,917.9133,128,066.77一年内到期的非流动资产其他流动资产流动资产合计480,301,755.48469,755,711.94123,915,868.90113,335,515.70非流动资产：发放贷款及垫款可供出售金融资产持有至到期投资长期应收款长期股权投资10,261,027.5910,261,027.59投资性房地产178,671.19178,671.19184,138.87184,138.87固定资产76,963,106.7576,898,940.1180,371,085.2680,301,828.64在建工程7,323,457.827,323,457.823,729,062.683,729,062.68南通精华制药股份有限公司2010年半年度财务报告2工程物资固定资产清理生产性生物资产油气资产无形资产9,931,447.839,931,447.8310,182,229.9410,182,229.94开发支出商誉长期待摊费用递延所得税资产1,586,840.331,586,840.331,987,731.391,987,731.39其他非流动资产非流动资产合计95,983,523.92106,180,384.8796,454,248.14106,646,019.11资产总计576,285,279.40575,936,096.81220,370,117.04219,981,534.81流动负债：短期借款25,000,000.0025,000,000.00向中央银行借款吸收存款及同业存放拆入资金交易性金融负债应付票据应付账款28,508,413.2028,145,644.1028,276,988.9127,868,189.65预收款项1,160,936.521,160,936.522,836,144.782,836,144.78卖出回购金融资产款应付手续费及佣金应付职工薪酬7,873,294.537,796,005.753,838,694.653,761,152.12应交税费4,203,823.454,249,390.637,075,501.927,117,430.07应付利息18,225.0018,225.00应付股利其他应付款9,299,625.089,299,625.0811,877,653.6311,877,653.63应付分保账款保险合同准备金代理买卖证券款代理承销证券款一年内到期的非流动负债其他流动负债409,249.36409,249.36693,514.98693,514.98流动负债合计51,455,342.1451,060,851.4479,616,723.8779,172,310.23非流动负债：长期借款应付债券长期应付款南通精华制药股份有限公司2010年半年度财务报告3专项应付款预计负债递延所得税负债其他非流动负债4,104,104.094,104,104.093,643,277.813,643,277.81非流动负债合计4,104,104.094,104,104.093,643,277.813,643,277.81负债合计55,559,446.2355,164,955.5383,260,001.6882,815,588.04所有者权益（或股东权益）：实收资本（或股本）80,000,000.0080,000,000.0060,000,000.0060,000,000.00资本公积374,906,788.70374,906,788.7022,737,816.7022,737,816.70减：库存股专项储备2,756,887.732,756,887.732,340,515.012,340,515.01盈余公积6,708,761.516,708,761.516,708,761.516,708,761.51一般风险准备未分配利润56,343,624.5556,398,703.3445,313,260.2945,378,853.55外币报表折算差额归属于母公司所有者权益合计520,716,062.49520,771,141.28137,100,353.51137,165,946.77少数股东权益9,770.689,761.85所有者权益合计520,725,833.17520,771,141.28137,110,115.36137,165,946.77负债和所有者权益总计576,285,279.40575,936,096.81220,370,117.04219,981,534.812、利润表编制单位：南通精华制药股份有限公司2010年1-6月单位：元本期金额上期金额项目合并母公司合并母公司一、营业总收入124,108,042.56123,787,980.13119,052,939.92118,730,700.51其中：营业收入124,108,042.56123,787,980.13119,052,939.92118,730,700.51利息收入已赚保费手续费及佣金收入二、营业总成本100,873,548.31100,569,697.14101,225,751.01100,959,591.65其中：营业成本59,825,799.1859,636,461.4562,217,106.0062,026,773.57利息支出手续费及佣金支出退保金赔付支出净额提取保险合同准备金净额保单红利支出南通精华制药股份有限公司2010年半年度财务报告4分保费用营业税金及附加1,197,650.421,195,649.341,420,675.881,418,913.25销售费用23,770,614.6023,770,614.6022,630,157.6122,630,157.61管理费用18,594,913.5818,472,867.2814,581,020.3614,505,057.08财务费用-2,037,374.50-2,027,840.56818,473.11820,381.11资产减值损失-478,054.97-478,054.97-441,681.95-441,690.97加：公允价值变动收益（损失以“-”号填列）投资收益（损失以“-”号填列）其中：对联营企业和合营企业的投资收益汇兑收益（损失以“-”号填列）三、营业利润（亏损以“-”号填列）23,234,494.2523,218,282.9917,827,188.9117,771,108.86加：营业外收入37,670.9637,670.9646,257.032,194.00减：营业外支出259,759.96258,253.25119,274.51118,730.70其中：非流动资产处置损失四、利润总额（亏损总额以“-”号填列）23,012,405.2522,997,700.7017,754,171.4317,654,572.16减：所得税费用3,982,032.163,977,850.913,292,086.303,286,092.86五、净利润（净亏损以“-”号填列）19,030,373.0919,019,849.7914,462,085.1314,368,479.30归属于母公司所有者的净利润19,030,364.2619,019,849.7914,462,041.0414,368,479.30少数股东损益8.8344.09六、每股收益：（一）基本每股收益0.250.250.240.24（二）稀释每股收益0.250.250.240.24七、其他综合收益八、综合收益总额19,030,373.0919,019,849.7914,462,085.1314,368,479.30归属于母公司所有者的综合收益总额19,030,364.2619,019,849.7914,462,041.0414,368,479.30归属于少数股东的综合收益总额8.8344.09南通精华制药股份有限公司2010年半年度财务报告53、现金流量表编制单位：南通精华制药股份有限公司2010年1-6月单位：元本期金额上期金额项目合并母公司合并母公司一、经营活动产生的现金流量：销售商品、提供劳务收到的现金133,968,984.98133,618,966.30125,482,851.14125,144,768.28客户存款和同业存放款项净增加额向中央银行借款净增加额向其他金融机构拆入资金净增加额收到原保险合同保费取得的现金收到再保险业务现金净额保户储金及投资款净增加额处置交易性金融资产净增加额收取利息、手续费及佣金的现金拆入资金净增加额回购业务资金净增加额收到的税费返还收到其他与经营活动有关的现金1,517,325.401,496,860.461,208,780.451,206,117.45经营活动现金流入小计135,486,310.38135,115,826.76126,691,631.59126,350,885.73购买商品、接受劳务支付的现金57,385,751.9257,158,179.0547,585,011.7147,400,594.65客户贷款及垫款净增加额存放中央银行和同业款项净增加额支付原保险合同赔付款项的现金南通精华制药股份有限公司2010年半年度财务报告6支付利息、手续费及佣金的现金支付保单红利的现金支付给职工以及为职工支付的现金18,232,466.7918,192,129.2315,065,557.2915,019,275.85支付的各项税费18,172,957.8718,127,047.9114,192,162.7214,167,964.77支付其他与经营活动有关的现金28,302,241.6028,239,978.3623,048,325.8723,021,106.13经营活动现金流出小计122,093,418.18121,717,334.5599,891,057.5999,608,941.40经营活动产生的现金流量净额13,392,892.2013,398,492.2126,800,574.0026,741,944.33二、投资活动产生的现金流量：收回投资收到的现金取得投资收益收到的现金处置固定资产、无形资产和其他长期资产收回的现金净额处置子公司及其他营业单位收到的现金净额收到其他与投资活动有关的现金投资活动现金流入小计购建固定资产、无形资产和其他长期资产支付的现金23,355,557.4223,355,557.42733,490.34733,490.34投资支付的现金质押贷款净增加额取得子公司及其他营业单位支付的现金净额支付其他与投资活动有关的现金投资活动现金流出小计23,355,557.4223,355,557.42733,490.34733,490.34投资活动产生的现金流量净额-23,355,557.42-23,355,557.42-733,490.34-733,490.34三、筹资活动产生的现金流量：南通精华制药股份有限公司2010年半年度财务报告7吸